Short Interest In Qiagen Decreases By 11.7%

The most recent short interest data has been released by the NASDAQ for the 01/31/2014 settlement date, which shows a 570,261 share decrease in total short interest for Qiagen N.V. ( QGEN), to 4,288,805, a decrease of 11.74% since 01/15/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for QGEN at the 01/31/2014 settlement increased to 1,323,004, as compared to 922,602 at the 01/15/2014 report. That brought "days to cover" down to 3.24, a 38.45% decrease from the 5.27 days to cover calculated at the previous short interest data release.

START SLIDESHOW:
Top 25 S.A.F.E. Dividend Stocks »

The below chart shows the historical "days to cover" for QGEN at previous short interest release dates:

Loading+chart++2014+TickerTech.com

A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where QGEN had been shorted as a hedge.

The chart below shows the one year performance of QGEN shares, versus its 200 day moving average. Looking at this chart, QGEN's low point in its 52 week range is $18.30 per share, with $24.82 as the 52 week high point — that compares with a last trade of $22.46.

If you liked this article you might like

Premarket Biotech Movers: Cytokinetics, Achillion, Qiagen

What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers

3 Diversified Services Stocks Nudging The Industry Higher

Qiagen (QGEN) Stock Soars as Q2 Results Surpass Expectations

Watch Out: Barbarians At The Gate For Qiagen (QGEN)